Press release
Pulmonary Edema Therapeutics Market Set for Breakthrough Growth Driven by Innovative Treatments 2025 | Top key players - Pfizer Inc., sanofi-aventis U.S. LLC, Purdue Phanna L.P.
Pulmonary Edema Therapeutics Market
The Pulmonary Edema Therapeutics Market is estimated to reach at a CAGR 3.3% during the forecast period (2024-2031).
The Pulmonary Edema Therapeutics Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Pulmonary Edema Therapeutics market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/pulmonary-edema-therapeutics-market?sz
The Pulmonary Edema Therapeutics Market refers to the global industry focused on developing and providing treatments that manage fluid accumulation in the lungs, improving oxygen exchange and patient outcomes. It includes pharmacological therapies, diuretics, vasodilators, supportive devices, and advanced treatment approaches addressing underlying causes such as heart failure, kidney disease, or acute lung injury.
Key Developments of USA and Japan:
USA (June - September 2025):
Lupin Limited Generic Drug Approval: In June 2025, Lupin Limited received FDA approval for a generic version of a combination tablet used to manage pulmonary edema, making treatment more accessible and affordable.
Insmed's BRINSUPRITM (brensocatib) Approval: The FDA approved BRINSUPRITM (brensocatib) on August 12, 2025, as the first and only treatment for non-cystic fibrosis bronchiectasis (NCFB), a condition that can lead to pulmonary edema.
Japan (June - September 2025):
Mochida Pharmaceutical's Tyvaso DPI Acquisition: Mochida Pharmaceutical acquired the Japanese distribution rights for Tyvaso DPI, an inhalation powder for pulmonary arterial hypertension (PAH), a condition related to pulmonary edema.
MSD's Airwin (sotatercept) Launch: MSD launched its new pulmonary arterial hypertension (PAH) therapy, Airwin (sotatercept), in the Japanese market in mid-August 2025. This therapy helps to reduce pulmonary arterial pressure.
Key Players:
Pfizer Inc.
Sanofi-aventis U.S. LLC
Purdue Phanna L.P.
Evus Pharmaceuticals, LLC
NovaDel Pharma Inc.
American Regent, Inc.
Medicure Inc.
Copperhead Chemical Company.
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=pulmonary-edema-therapeutics-market
Market Segmentation:
By Drug Class: Diuretics, Opioid Analgesics, Vasodilators, Antihypertensives, Inotropes, Others.
By Type: Cardiogenic Pulmonary Edema, Non-cardiogenic Pulmonary Edema.
By Route of Administration: Oral, Intravenous.
By Distribution Channel: Hospital, Pharmacies, Retail Pharmacies, Online Pharmacies, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pulmonary-edema-therapeutics-market?sz
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Pulmonary Edema Therapeutics market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Pulmonary Edema Therapeutics Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Pulmonary Edema Therapeutics market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Pulmonary Edema Therapeutics Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Pulmonary Edema Therapeutics Market in 2025?
◆ What is the projected growth rate of the Pulmonary Edema Therapeutics Market through 2033?
◆ Who are the key players in the Pulmonary Edema Therapeutics Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Edema Therapeutics Market Set for Breakthrough Growth Driven by Innovative Treatments 2025 | Top key players - Pfizer Inc., sanofi-aventis U.S. LLC, Purdue Phanna L.P. here
News-ID: 4176704 • Views: …
More Releases from DataM Intelligence 4Market Research
Breathing Disorder Treatment Market Projected for Robust Growth Amid Rising COPD …
Market Overview:
The Breathing Disorder Treatment Market is expected to grow at a CAGR of 4.8% during the forecast period 2024-2031.
The Breathing Disorder Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Breathing Disorder Treatment market report is an essential…
Anticoagulation Therapy Market Poised for Breakthrough Innovations and Billion-D …
Market Overview:
The Global Anticoagulation Therapy Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
The Anticoagulation Therapy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Anticoagulation Therapy market report is an essential resource for market…
Bleeding Disorders Treatment Market Accelerates with Expanding Biopharma R&D Inv …
Market Size and Growth:
The Global Bleeding Disorders Treatment Market Size reached US$ 5.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 11.2 billion by 2030. The global bleeding disorders treatment market is expected to exhibit a CAGR of 8.4% during the forecast period 2024-2031.
The Bleeding Disorders Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market.…
Blood Clotting Factors Market Set for Breakthrough Growth Driven by Advanced Bio …
Market Overview:
The Blood Clotting Factors Market is predicted to reach at a CAGR of 6.9% during the forecast period (2024-2031).
The Blood Clotting Factors Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Blood Clotting Factors market report is an essential…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
